Case Report

 

 

 

 

 

Synchronous Occurrence of Small Intestinal Stromal Tumor and

Cecal Adenocarcinoma

 

Shifteh Vahidi MD*, Azadeh Rakhshan MD*

 

 

Authors' affiliation: *Department of Pathology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

•Corresponding author and reprints: Shifteh Vahidi MD, Department of Pathology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

E-mail:shifteh2000@yahoo.com

 

Accepted for publication:15 August 2008



Synchronous development of gastrointestinal stromal tumors with other tumors in the digestive tract is relatively rare, and often occurs in the stomach.  We report a 76-year-old woman, who suffered from the exceedingly rare synchronous development of small intestinal stromal tumor and cecal adenocarcinoma. The patient presented with intestinal obstructive symptoms. The pre-operative abdominal ultrasonography demonstrated a very large heterogenous periumbilical mass. Laparotomy was performed and the evaluation of the surgical specimen revealed a huge 14-cm subserosal mass of high risk ileal stromal tumor along with cecal adenocarcinoma with regional lymph node metastasis. The patient died within 3 months of diagnosis.

 

 Archives of Iranian Medicine, Volume 11, Number 6, 2008: 665 – 668.

 

Keywords: Adenocarcinoma · gastrointestinal stromal tumor · multiple primary neoplasms


Introduction
 

G

astrointestinal stromal tumors (GISTs) constitute the most frequent group of mesenchymal neoplasms in the gastrointestinal tract.1 They have been distinctly separated from leiomyomas, leiomyosarcomas, and schwannomas according to clinicopathological differences and immunohistochemical studies.2,3 They are considered to arise from the interstitial cells of Cajal (ICC) in the digestive tract.4 Mutations of c-kit  proto-oncogene that normally encodes the KIT receptor tyrosine kinase (CD117) in the Cajal cells seem to be responsible for activation of KIT receptor and stimulation of cell growth.5 Thus, consistent immunohistochemical staining for CD117/KIT is noted in all histologic variants of GISTs.6

The most frequent anatomic sites of these tumors are stomach, small intestine, colorectum, and esophagus, respectively.7 Synchronous occurrence of GISTs with other tumors in the gastrointestinal tract have been reported rarely in the literature. There are some case reports and case series about the coincidence of GISTs with gastrointestinal adenocarcinomas,1,7 adenocarci-noma  arising in villous adenoma of the ampulla of Vater,8 mucosa-associated lymphoid tissue lymphoma,9 carcinoid tumor,7 duodenal Brunner’s gland adenoma,1 neurofibroma, and somatostatinoma of the ampulla of Vater.10

 

Case Report

 

A 76-year-old woman was admitted to the emergency room of our hospital, because of progressive periumbilical abdominal pain over the past three days, associated with nausea, vomiting, and obstipation. Her medical, drug, and family history were unremarkable.

On physical examination, the abdomen was distended, having five bowel sounds per minute. Epigastric and periumbilical regions were tender in deep palpation. The vital signs, rectal exam, and other examinations were all normal. Abdominal ultrasonography revealed a very large heterogenous mass in periumbilical and hypogastric regions, surrounded by distended intestinal loops, which were filled by fluid and gas. Celiac or mesenteric lymphadenopathy and ascites were not identified. Liver and pancreas appeared normal. The sonographic impression was a gastrointestinal neoplasm (Figure 1). Abnormal laboratory findings were as follows: hemoglobin (HB): 10.4 g/dL, mean cell volume (MCV): 76 fl, mean cell hemoglobin (MCH): 25 pg, mean cell hemoglobin concentration (MCHC): 33.8 g/dL, serum glucose: 200 mg/dL, urea: 95 mg/dL, and creatinine: 1.6 mg/dL.

 

fIG-1

Figure 1. Preoperative abdominal sonography revealed a very large heterogenous periumbilical mass.

 

 

At laparotomy, a huge ileal mass and a tumoral lesion in cecum were identified and partial resection of the ileum along with right hemicolectomy was performed. Macroscopic examination of the ileal segment revealed a huge, grayish-brown subserosal mass, measuring 14×10×8 cm and weighing 700g, located in the mesenteric side of the ileum. The ileal mucosa appeared normal, but the lumen was narrowed due to mass effect. The cut surface of the mass was tan-brown, solid, with hemorrhagic areas.

Macroscopic evaluation of the cecum, demonstrated a white firm, infiltrative tumoral lesion with superficial necrosis, measuring 8×5×3 cm.

Microscopically, the ileal mass was a neural type gastrointestinal stromal tumor, originated from the outer layers of the muscularis mucosa. The tumor was composed of spindle cells showing palisading and whorl-like configurations, with areas of hemorrhage and necrosis (Figure 2). Twelve mitotic figures per 50 HPF (>10/50 HPF) and the large size of the tumor (>10cm), placed this neoplasm in the high-risk category (according to risk categories for GISTs from Fletcher et al.).11

 

FIG-2

Figure 2. The ileal tumor composed of spindle cell showing palisading and whorl-like configurations.

 

The tumor cells were immunoreactive for CD117 (c-kit), vimentin, S-100, and neuron specific enolase (NSE). They were negative for cytokeratin, CD 34, desmin, and actin (Figure 3).

 

FIG-3

Figure 3. The tumor cells are immunoreactive for
CD 117.

 

Microscopic    evaluation   of   the cecal  lesion, revealed a moderately differentiated adenoacar- cinoma with extension into the pericolic fat and appendix, vascular invasion, and involvement of six regional lymph nodes. Cecal margin was involved by adenocarcinoma. The patient died within 3 months of diagnosis.

 

Discussion
 

The simultaneous development of GISTs and adenocarcinomas of digestive tract are mainly described as case reports and case series. Most of them have been reported in the stomach.7,12–16

In a series of 200 cases of GISTs studied by urbanczyk et al. synchronous tumors were present in seven patients, including one adenocarcinoma of colon.7

In the study by Wronski et al. on 28   patients with GISTs, four gastric stromal tumors
(14% of patients) were found with a second neoplasm, including two gastric adenocarcinomas, one colon adenocarcinoma, and a gastric lymphoma.17 Few reports of synchronous gastric stromal tumor with large bowel and pancreatic adenocarcinoma also exist.18,19

Although it seems that the synchronous occurrence of stromal and epithelial neoplasms of gastrointestinal tract is more common than it has been considered, small bowel stromal tumor concomitant with colon adenocarcinoma is virtually rare. A Hungarian study on 43 patients with GISTs, revealed seven patients with a second tumor, including three small intestinal GISTs occurring metachronous or synchronous with colorectal adenocarcinoma.1 Melis et al. also reported two cases of small bowel stromal tumor with synchronous invasive colon adeno-carcinoma.20

In the presented case, the cecal adenocarcinoma was clinically silent and the patient’s symptoms were mainly due to the mass effect of small intestinal stromal tumor. In a report by Kövér et al., the stromal tumors in four of seven synchronous tumors were silent. This confirms the importance of surgical intra-abdominal control before closure.1

Recently, it is believed that the combination of tumor size and mitotic activity is the most important prognostic factor in GISTs.11 Poor prognosis of this patient is simply explained by the presence of a high-risk GIST and an adenocarcinoma with lymph node metastasis.

The etiology of synchronous gastrointestinal stromal and epithelial tumors is unknown, but some theories exist. In areas with high incidence of gastrointestinal cancers the coincidence alone can easily account for such an association. Otherwise gene mutations might interact with two neighboring tissues inducing the development of different tumors in these areas.14

 

References

 

1         Kövér E, Faluhelyi Z, Bogner B, Kalmár K, Horváth G, Tornóczky T. Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms [in Hungarian]. Magy Onkol. 2004; 48: 315 – 321.

2         Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000; 24: 1339 – 1352.

3         Mikttinen M, virolainen M, Sarlomo-Rikala M. Gastrointestinal stromal tumors-value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol. 1995; 19: 207 – 216.

4         Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999; 23: 377 – 389.

5         Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol. 2002; 33:
466 – 477.

6         Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11: 728 – 734.

7         Urbańczyk K, Limon J, Korobowicz E, Chosia M, Sygut J, Karcz D, et al. Gastrointestinal stromal tumors. A multicenter experience. Pol J Pathol. 2005; 56: 51 – 61.

8         Aksoy NH, Cevikol C, Ogüs M, Elpek GO, Gelen T. Adenocarcinoma arising in villous adenoma of the ampulla of Vater with synchronous malignant gastrointestinal stromal tumour of the duodenum: a case report. J clin Pathol. 2004; 57: 118 – 119.

9         Kaffes A, Hughes L, Hollinshead J, Katelaris P. Synchronous primary adenocarcinoma, mucosa-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomach. J Gastroenterol Hepatol. 2002; 17: 1033 – 1036.

10      Suzuki S, Sato K, Katada E, Kuno Y, Mizoguchi N, Tokuda H, et al. Periampullary somatostatinoma and multiple gastrointestinal stromal tumors associated with von Recklinghausen's disease. J Gastroenterol. 2004; 39: 1011 – 1012.

11      Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2000; 33: 459 – 465.

12      Bircan S, Candır O, Aydın S, Başpınar S, Bülbül M, Kapucuoğlu N, et al. Synchronous primary adenocarcinoma and gastrointestinal stromal tumor in the stomach: A report of two cases. Turk J Gastroenterol. 2004; 15: 187 – 191.

13      Rauf F, Ahmad Z, Muzzafar S, Hussaini AS. Synchronous occurrence of gastrointestinal stromal tumor and gastric adenocarcinoma: a case report. J Pak Med Assoc. 2006; 56: 184 – 186.

14      Maiorana A, Fante R, Maria Cesinaro A, Adriana Fano R. Synchronous occurrence of epithelial and stromal tumors in the stomach. A report of 6 cases. Arch Pathol Lab Med. 2000; 124: 682 – 686.

15      Rubiales AS, Ovelar Y, Beltrán de Heredia J, del Valle ML. Synchronous diagnosis of gastric adenocarcinoma and GIST [in Spanish].  An Med Interna. 2005; 22: 606 – 607.

16      Lin YL, Tzeng JE, Wei CK, Lin CW. Small gastrointestinal stromal tumor concomitant with early gastric cancer: a case report. World J Gastroenterol. 2006; 12: 815 – 817.

17      Wronski M, Ziarkiewicz-Wroblewska B, Gornicka B, Cebulski W, Slodkowski M, Wasiutynski A, et al.  Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms. World J Gastroenterol.  2006; 12: 5360 – 5362.

18      M'sakni I, Rammeh S, Chelbi E, Sayari S, Zaouech A, Baltagi-Ben Jilani S, et al. Adenocarcinoma and gastrointestinal stromal tumor: fortuitous  association or a single carcinogenic agent? A report of 2 cases. Ann Chir. 2006; 131: 464 – 467.

19      Kumar S, Kumar S, Bakshi SD, Sengupta S, Ghosh S, Jindal R.  Synchronous gastric stromal tumor and cecal adenocarcinoma. Indian J Gastroenterol. 2005; 24: 169 – 170.

20      Melis M, Choi EA, Anders R, Christiansen P, Fichera A. Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor (GIST). Int J Colorectal Dis. 2007; 22: 109 – 114.


AIM Home | Table of Contents